Flossbach Von Storch’s Dr. Reddy's Laboratories RDY Stock Holding History

Flossbach Von Storch’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-40,000	Closed	-$285K	–	106
2017 Q3	$285K	Sell	40,000 -130,000	-76%	-$935K	﹤0.01%	98
2017 Q2	$1.43M	Hold	170,000	–	–	0.02%	82
2017 Q1	$1.36M	Buy	170,000 +7,500	+5%	+$64.8K	0.02%	84
2016 Q4	$1.47M	Sell	162,500 -37,500	-19%	-$349K	0.02%	85
2016 Q3	$1.86M	Buy	200,000 +20,000	+11%	+$191K	0.03%	74
2016 Q2	$1.84M	Hold	180,000	–	–	0.03%	73
2016 Q1	$1.63M	Buy	180,000 +5,000	+3%	+$44.7K	0.03%	79
2015 Q4	$1.62M	Buy	175,000 +85,000	+94%	+$931K	0.03%	84
2015 Q3	$1.15M	Sell	90,000 -25,000	-22%	-$311K	0.02%	82
2015 Q2	$1.27M	Sell	115,000 -7,500	-6%	-$82.8K	0.02%	82
2015 Q1	$1.4M	Buy	122,500 +12,500	+11%	+$133K	0.03%	79
2014 Q4	$1.11M	Buy	110,000 +90,000	+450%	+$947K	0.03%	83
2014 Q3	$210K	Sell	20,000 -10,000	-33%	-$94K	﹤0.01%	92
2014 Q2	$259K	Buy	+30,000	New	+$252K	0.01%	84

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Flossbach Von Storch's RDY Position: Q4 2017 in Review

Flossbach Von Storch sold out of Dr. Reddy's Laboratories (RDY) in Q4 2017, closing a stake of 40,000 shares — an estimated $285K sold.

Flossbach Von Storch first reported a position in RDY in Q2 2014 and held it in 14 quarters. The position peaked at $1.86M in Q3 2016. 118 funds tracked by Wall St. Rank hold RDY as of Q4 2017.

Flossbach Von Storch reported no remaining Dr. Reddy's Laboratories position as of Q4 2017 after selling out during the quarter.
Flossbach Von Storch sold 40,000 Dr. Reddy's Laboratories shares in Q4 2017, an estimated $285K.
Flossbach Von Storch first reported a position in Dr. Reddy's Laboratories in Q2 2014 and held it in 14 quarters.
Flossbach Von Storch's Dr. Reddy's Laboratories position peaked at $1.86M in Q3 2016.
118 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2017.

Based on Flossbach Von Storch's 13F filing for Q4 2017, filed 7 Feb 2018.